[PDF] Top 20 Formulation development and evaluation of medroxyprogesterone acetate injectable suspension
Has 10000 "Formulation development and evaluation of medroxyprogesterone acetate injectable suspension" found on our website. Below are the top 20 most common "Formulation development and evaluation of medroxyprogesterone acetate injectable suspension".
Formulation development and evaluation of medroxyprogesterone acetate injectable suspension
... Aqueous suspension of medroxy progesterone acetate was prepared by rapid stirring method. Accurately weighed quantity of PEG-3350, poloxamer 188, Polysorbate 80, benzyl alcohol and sodium chloride was ... See full document
6
Formulation development and evaluation of fast dissolving film of telmisartan
... Hypertension is a major cause of concern not just in the elderly but also in the youngsters. An effort was made to formulate a fast dissolving film containing telmisartan which is used in the treatment of hypertension ... See full document
5
Formulation Development and Evaluation of Niosomal Gel of Combined Anti-Fungal Agents
... best formulation as it showed promising qualities of a gel with a maximum release of ...topical formulation with a high degree of skin permeation and prolongs maintenance of drug by increasing the retention ... See full document
18
Formulation Development and Evaluation of Taste Masked Cefuroxime Axetil Oral Suspension
... The bitter taste of the drugs, which are orally administered, is disadvantageous in several aspects. Taste is an important parameter governing the compliance. “The worse the taste of the medication, the better the cure” ... See full document
125
Formulation Development and Evaluation of Diltiazem Hydrochloride Oral Disintegrating Tablets
... Disintegration results shown that the tablets containing SSG had much more effect on disintegration with respect to concentration, where as CP also shown good disintegration ability with in the time limit but lesser ... See full document
6
Formulation development and evaluation of rapidly disintegrating antacid tablets
... Aluminum hydroxide is an effective oral antacid. It is available in form of dried aluminum hydroxide gel consist largely of hydrated aluminium oxide together with varying quantities of basic aluminium carbonate & ... See full document
5
Formulation development and evaluation of smart polymer gel formulation for ophthalmic drug delivery
... irritative and comfortable form and optimum An ultimate ocular carrier system would be designed h no blurred vision/irritation. This would need one to three applications a day. The usefulness to patient is simplicity, a ... See full document
8
Formulation Development and Evaluation of Suspension of Gatifloxacin using Suspending Agent
... It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. As a result, it is approved by the Food and Drug Administration for the treatment of community- ... See full document
10
FORMULATION AND EVALUATION OF AN INJECTABLE SOLUTION AS A DOSAGE FORM
... pharmaceutical development of an injectable ...process development and presents findings as a knowledge- based report, where relevant, supporting data have been summarized in appropriate dosage form ... See full document
7
Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate
... prednisolone acetate (MPA), a steroidal anti‑inflammatory drug is widely used in musculoskeletal disorders such as arthritis and dysmenorrhea for symptomatic relief of pain and inflammation [1] .... ... See full document
5
Safety of an extended release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
... was 50-fold lower at 9.37 ng/ml [7]. Other safety objec- tives, including safety in reproducing male and female dogs, heartworm-positive dogs, and ivermectin-sensitive Collies, had been established prior to ... See full document
13
FORMULATION AND CHARECTERIZATION OF IN SITU IMPALNT OF OCTREOTIDE ACETATE
... proposed enabling their sustained release after a residence time in the polymer which protects the peptide against enzymatic and hydrolytic influences of biological media [1] . Polymeric drug delivery systems are ... See full document
9
A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral Contraceptive Pill as Contraception
... (Norplant), Medroxyprogesterone Acetate (Depo-Provera), or the Combined Oral A Prospective Study of Adolescents Who Choose Among Levonorgestrel Implant. Services[r] ... See full document
10
Satheesh VM*, Ramesh Reddy K, Umasankar K, Jayachandra Reddy P
... a formulation, optimization and evaluation of raft forming suspension of Ranitidine using different raft forming agents Sodium Alginate, Guar gum, Carbopol 974P, and Xanthan gum used in combination ... See full document
13
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
... increasing. When considering the metabolic changes associated with both bariatric surgery and contraceptive use, in combination with the unique medical considerations of obese women, it is indisputable that clear ... See full document
8
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells
... for development of breast cancer is based in part on the increased proliferative activity observed in normal breast during the luteal phase of the menstrual cycle associated with rising progesterone levels ... See full document
15
“Meloxicam Depot Parenteral Bio-Degradable Microspheres: Preparation, Characterization and In-Vivo Evaluation” by Ahmed F. AbdelWahab, Amal K. Hussein, Khaled A. Khaled, Osama A. A. Ahmed, Saudi Arabia.
... release injectable microspheres of the anti-inflammatory drug Meloxicam ...the formulation parameters on the characteristics of the prepared microspheres was investigated to achieve formulation with ... See full document
8
Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
... prednisolone acetate, which were not shaken prior to use, demonstrated the greatest concentration variability of all suspension bottles ...prednisolone acetate concentrations from the inverted ... See full document
6
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent
... The in vivo studies completed with Cu(DDC) 2 produced in DSPC/Chol liposomes indicated that the drug was rapidly eliminated from plasma after iv administration (.90% of the injected dose was eliminated within 15 min, ... See full document
18
Bioadhesive Inserts of Prednisolone Acetate for Postoperative Management of Cataract – Development and Evaluation
... On the basis of evaluation parameters the formulation PEF-06, 08, 11 and 13 was optimized and further studies were conducted only on optimised batches. The invitro drug release study showed extended drug ... See full document
8
Related subjects